By : Dave Hodges
17 Sep, 2014
I have previously reported that Monsanto, or Monsatan as many call them, has partnered with the Department of Defense to use a proxy third party company to develop a vaccine against Ebola. The seed money began at $1.5 million. The value of the deal could grow to an estimated $86 million dollars. The company’s name is Tekmira Pharmaceuticals Corporation (TKMR) (TKM.TO), a leading developer of RNA interference (RNAi) therapeutics.